Somatostatin analogue inhibits the mobility of prostate carcinoma cells: A new therapeutic method for advanced prostate carcinoma

International Journal of Oncology

Volumn 37, Issue 5, 2010, Pages 1077-1083

  Tang, XiaoYan ^a   Takekoshi, Susumu ^a   Itoh, Johbu ^a   Umemura, Shinobu ^a   Shoji, Sunao ^a   Terachi, Toshiro ^a   Osamura, Robert Yoshiyuki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Prostate carcinoma; Somatostatin; Somatostatin analogue; Somatostatin receptor 2a

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OCTREOTIDE; RHO KINASE INHIBITOR; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 2A; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; DRUG INHIBITION; DRUG RECEPTOR BINDING; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 77957867136     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000759     Document Type: Article

References (22)

1. Weckbecker G, Lewis I, Albert R, et al: Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev/Drug Discovery 2: 999-1017, 2003. (Pubitemid 37540581)
2. Florio T: Somatostatin/somatostatin receptor signaling: Phosphotyrosine phosphatases. Mol Cell Endocrinol 286: 40-48, 2008.
3. Lahlou H, Saint-Laurent N, Esteve JP, et al: sst2 Somatostatin receptor inhibits cell proliferation through RAS-, Rap1-, and B-raf-dependent ERK2 activation. J Biol Chem 278: 39356-39371, 2003. (Pubitemid 37248491)
4. Narumiya S: The small GTPase Rho: cellular functions and signal transduction. J Biochem 120: 215-228, 1996.
5. Kaverina I, Krylyshkina O and Small JV: Regulation of substrate adhesion dynamics during cell motility. Int J Biochem Cell Biol 34: 746-761, 2002. (Pubitemid 34304165)
6. Enomot T: Microtubules disruption induces the formation of actin stress fibers and focal adhesions in cultured cells: possible involve-ment of the Rho signal cascade. Cell Struct Funct 21: 317-326, 1996.
7. Raman N and Atkinson SJ: Rho controls actin cytoskeletal assembly in renal epithelial cells during ATP depletion and recovery. Am J Physiol 276: C1312-C1324, 1999. (Pubitemid 29323396)
8. Ishizaki T, Uehata M, Tamechika I, et al: Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol 57: 976-983, 2000. (Pubitemid 30253382)
9. Buchan AM, Lin CY, Choi J, et al: Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration. J Biol Chem 277: 28431-28438, 2002.
10. Saras J, Grönberg M, Stridsberg M, et al: Somatostatin induces rapid contraction of neuroendocrine cells. FEBS Lett 581: 1957-1962, 2007.
11. Rubin MA: Targeted therapy of cancer: new roles for pathologists-prostate cancer. Mod Pathol 21: S44-S55, 2008.
12. Hejna M, Schmidinger M and Raderer M: The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol 13: 653-668, 2002.
13. Kosari F, Munz JMA, Savci-Heijink CD, et al: Identification of prognostic biomarkers for prostate cancer. Clin Cancer Res 14: 1734-1743, 2008.
14. Halmos G, Schally AV, Sun B, et al: High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers. J Clin Endocrinol Metab 85: 2564-2571, 2000.
15. Liu Z, Marquez M, Nilsson S, et al: Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. Oncol Rep 20: 151-154, 2008.
16. Dizeyi N, Konrad L, Bjartell A, et al: Localization and mRNA expression of somatostatin receptor subtypes inhuman prostatic tissue and prostate cancer cell lines. Urol Oncol 7: 91-98, 2002.
17. Plonowski A, Schally AV, Nagy A, et al: Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic Somatostatin Analogue AN-238. Cancer Res 59: 1947-1953, 1999.
18. Fukata M, Nakagawa M, Kurda S, et al: Cell adhesion and Rho small GTPases. J Cell Sci 112: 4491-4500, 1999. (Pubitemid 30034799)
19. Watanabe N, Kato T, Fujita A, et al: Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol 1: 136-143, 1999. (Pubitemid 129656017)
20. Papadopoulou N, Charalampopoulo I, Alevizopoulos K, et al: Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res 314: 3162-3174, 2008.
21. Sequeira L, Dubyk CW, Riesenberger TA, et al: Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin Exp Metastasis 25: 569-579, 2008.
22. Dimopoulos MA, Kiamouris C, Gika D, et al: Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: A randomized phase II study. Urology 63: 120-125, 2004. (Pubitemid 38147563)